PA8448801A1 - Inhibidores de la proteasa del vih - Google Patents

Inhibidores de la proteasa del vih

Info

Publication number
PA8448801A1
PA8448801A1 PA19988448801A PA8448801A PA8448801A1 PA 8448801 A1 PA8448801 A1 PA 8448801A1 PA 19988448801 A PA19988448801 A PA 19988448801A PA 8448801 A PA8448801 A PA 8448801A PA 8448801 A1 PA8448801 A1 PA 8448801A1
Authority
PA
Panama
Prior art keywords
hiv protease
hiv
protease inhibitors
compounds
viruses
Prior art date
Application number
PA19988448801A
Other languages
English (en)
Spanish (es)
Inventor
Kim ALBIZATI
Siegfried Heinz Reich
Michael D Varney
Kanyin E Zhang
Takuo Kobayashi
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of PA8448801A1 publication Critical patent/PA8448801A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PA19988448801A 1997-03-13 1998-03-13 Inhibidores de la proteasa del vih PA8448801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13

Publications (1)

Publication Number Publication Date
PA8448801A1 true PA8448801A1 (es) 2000-05-24

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988448801A PA8448801A1 (es) 1997-03-13 1998-03-13 Inhibidores de la proteasa del vih

Country Status (35)

Country Link
EP (1) EP0970055A2 (ko)
JP (1) JP2001516350A (ko)
KR (1) KR100511089B1 (ko)
CN (1) CN1179948C (ko)
AP (1) AP1358A (ko)
AR (1) AR012556A1 (ko)
AU (1) AU743078B2 (ko)
BG (1) BG63540B1 (ko)
BR (1) BR9808867A (ko)
CA (1) CA2284163A1 (ko)
CO (1) CO4940496A1 (ko)
CZ (1) CZ296647B6 (ko)
EA (1) EA002378B1 (ko)
EE (1) EE04114B1 (ko)
GE (1) GEP20022764B (ko)
HR (1) HRP980112A2 (ko)
HU (1) HUP0001380A3 (ko)
IL (2) IL131870A0 (ko)
IS (1) IS5176A (ko)
MX (1) MXPA99008395A (ko)
MY (1) MY117535A (ko)
NO (1) NO315555B1 (ko)
NZ (1) NZ337706A (ko)
OA (1) OA11196A (ko)
PA (1) PA8448801A1 (ko)
PE (1) PE58799A1 (ko)
PL (1) PL192786B1 (ko)
SA (1) SA98181116B1 (ko)
SK (1) SK283636B6 (ko)
SV (1) SV1998000038A (ko)
TR (1) TR199902508T2 (ko)
TW (1) TW200517112A (ko)
UA (1) UA57772C2 (ko)
WO (1) WO1998040357A2 (ko)
ZA (1) ZA982047B (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
SV1998000038A (es) 1999-02-15
MY117535A (en) 2004-07-31
IL131870A0 (en) 2001-03-19
CN1253548A (zh) 2000-05-17
NO994415D0 (no) 1999-09-10
ZA982047B (en) 1998-09-28
HUP0001380A3 (en) 2001-12-28
TR199902508T2 (xx) 2000-02-21
EE04114B1 (et) 2003-08-15
SK283636B6 (sk) 2003-11-04
CZ319199A3 (cs) 2000-06-14
HUP0001380A2 (hu) 2000-09-28
IS5176A (is) 1999-09-10
CN1179948C (zh) 2004-12-15
SA98181116B1 (ar) 2006-10-04
EA002378B1 (ru) 2002-04-25
BG103727A (en) 2000-04-28
KR100511089B1 (ko) 2005-08-31
AU6457598A (en) 1998-09-29
WO1998040357A3 (en) 1998-11-26
CO4940496A1 (es) 2000-07-24
MXPA99008395A (es) 2003-08-12
NO315555B1 (no) 2003-09-22
KR20000076236A (ko) 2000-12-26
SK122299A3 (en) 2000-05-16
PL192786B1 (pl) 2006-12-29
BR9808867A (pt) 2000-07-11
PL335672A1 (en) 2000-05-08
EP0970055A2 (en) 2000-01-12
AP9901648A0 (en) 1999-09-30
AU743078B2 (en) 2002-01-17
PE58799A1 (es) 1999-07-12
HRP980112A2 (en) 1998-12-31
AR012556A1 (es) 2000-11-08
UA57772C2 (uk) 2003-07-15
EA199900823A1 (ru) 2000-04-24
TW200517112A (en) 2005-06-01
JP2001516350A (ja) 2001-09-25
CZ296647B6 (cs) 2006-05-17
BG63540B1 (bg) 2002-04-30
AP1358A (en) 2004-12-03
CA2284163A1 (en) 1998-09-17
NZ337706A (en) 2001-04-27
WO1998040357A2 (en) 1998-09-17
IL131870A (en) 2006-04-10
NO994415L (no) 1999-11-10
OA11196A (en) 2003-05-21
EE9900416A (et) 2000-04-17
GEP20022764B (en) 2002-08-26

Similar Documents

Publication Publication Date Title
ES2181725T3 (es) Inhibidores de hiv proteasa.
ES2171670T3 (es) Sulfonamidas que contienen heterociclos oxigenados como inhibidores de la aspartil proteasa.
ES2151600T3 (es) Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih.
MX9307821A (es) Nueva clase de inhibidores de proteasa aspartilo.
BR9813651A (pt) Compostos antipicornavirais e métodos para o seu uso e preparação
ES2065471T3 (es) Composiciones acuosas antibacterianas que comprenden un tensoactivo y bacteriofagos.
AR031520A1 (es) Un compuesto inhibidor de aspartilo proteasa, una composicion que lo comprende y un metodo para tratar un paciente con dicha composicion
BR0009485A (pt) Método e composições para evitar ou reduzir infecção por hiv pelo uso de inibidores para leucina aminopeptidase
EA200400026A1 (ru) Ингибиторы вич-протеазы, содержащие их композиции, их фармацевтические применения и вещества для их синтеза
PA8429901A1 (es) Compuestos antipicornavirales y metodos para su uso y preparacion
ES2101252T3 (es) Inhibidores de la proteasa del hiv utiles para el tratamiento del sida.
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
UY28048A1 (es) Inhibidores de hiv-integrasa,composiciones farmacéuticas y métodos para su uso
ES2132383T3 (es) Inhibidores de proteasa hiv.
PA8448801A1 (es) Inhibidores de la proteasa del vih
ECSP982442A (es) Inhibidores de la proteasa del vih
GT199800049A (es) Metodo para la obtencion de inhibidores de la proteasa del vhi.
ES2076248T3 (es) Dibenzofuranos substituidos y metodos para el uso de los mismos.
AR013087A1 (es) Forma v de amprenavir, su uso como compuesto antiviral, un proceso para prepararlo, y composiciones farmaceuticas que lo comprenden
EE9900188A (et) HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread
DOP2003000733A (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
ES2081782T3 (es) Extractos procedentes de piliostigma thonningil, su uso y formulaciones que los contienen.
UY26744A1 (es) Metodos para producir inhibidores de vih- proteasa y productos intermedios para producir inhibidores de vih- proteasa
ECSP003786A (es) Gama-hidroxil-2 (fluoroalquiloaminocarbonil)-1-piperacinapentanamidas y usos de ellas
UY27331A1 (es) Inhibidores de la proteasa del vih, composiciones que los contienen, sus usos farmacéuticos y materiales para su síntesis